<code id='412D14AB72'></code><style id='412D14AB72'></style>
    • <acronym id='412D14AB72'></acronym>
      <center id='412D14AB72'><center id='412D14AB72'><tfoot id='412D14AB72'></tfoot></center><abbr id='412D14AB72'><dir id='412D14AB72'><tfoot id='412D14AB72'></tfoot><noframes id='412D14AB72'>

    • <optgroup id='412D14AB72'><strike id='412D14AB72'><sup id='412D14AB72'></sup></strike><code id='412D14AB72'></code></optgroup>
        1. <b id='412D14AB72'><label id='412D14AB72'><select id='412D14AB72'><dt id='412D14AB72'><span id='412D14AB72'></span></dt></select></label></b><u id='412D14AB72'></u>
          <i id='412D14AB72'><strike id='412D14AB72'><tt id='412D14AB72'><pre id='412D14AB72'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:1219

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          Wikipedia

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          NVIDIA and Google execs on the future of AI and drug discovery
          NVIDIA and Google execs on the future of AI and drug discovery

          STAT'sCaseyRoss(left)andKimberlyPowell,NVIDIA'svicepresidentforhealthcareattheSTATBreakthroughSummit

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          HHS's proposed rule does nothing to address the climate crisis

          MariamZuhaib/APInApril,theU.S.DepartmentofHealthandHumanServices,theworld’smostpowerfulhealthcareage